Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts

Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial disease (PAD), is the main cause of death, with an annual mortality incidence predicted to rise to 23.3 million worldwide by 2030. Current revascularization techniques consist of angioplasty, placement of a st...

Full description

Bibliographic Details

Published in:	Frontiers in Bioengineering and Biotechnology
Main Authors:	Michele Carrabba, Paolo Madeddu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Subjects:	tissue engineering vascular conduits myocardial ischemia regenerative medicine stem cells
Online Access:	http://journal.frontiersin.org/article/10.3389/fbioe.2018.00041/full